About Correlia Biosystems
Correlia Biosystems is a company based in Berkeley (United States) founded in 2013. It operates as a HealthTech. Correlia Biosystems has raised $10.95 million across 7 funding rounds from investors including HHS, Neotribe and Cota Capital. Correlia Biosystems offers products and services including PIXI Benchtop Automated Immunoassays. Correlia Biosystems operates in a competitive market with competitors including Abingdon Health, Olink, Spear Bio, US BioTek Laboratories and Eclipse Bio, among others.
- Headquarter Berkeley, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Correlia Biosystems
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.95 M (USD)
in 7 rounds
-
Latest Funding Round
$1.25 M (USD), Series A
May 09, 2023
-
Investors
HHS
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Correlia Biosystems
Correlia Biosystems offers a comprehensive portfolio of products and services, including PIXI Benchtop Automated Immunoassays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated protein quantification using microfluidic gel technology.
Funding Insights of Correlia Biosystems
Correlia Biosystems has successfully raised a total of $10.95M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.25 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $1.3M
-
First Round
First Round
(01 Jul 2014)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series A - Correlia Biosystems | Valuation |
investors |
|
| Oct, 2020 | Amount | Series A - Correlia Biosystems | Valuation | Neotribe | |
| Jun, 2018 | Amount | Seed - Correlia Biosystems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Correlia Biosystems
Correlia Biosystems has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Neotribe and Cota Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
Stage-agnostic venture capital investments are focused on US sectors.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Correlia Biosystems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Correlia Biosystems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Correlia Biosystems Comparisons
Competitors of Correlia Biosystems
Correlia Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, Spear Bio, US BioTek Laboratories and Eclipse Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Provider of products and services for human protein biomarker research and development
|
|
| domain | founded_year | HQ Location |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| domain | founded_year | HQ Location |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| domain | founded_year | HQ Location |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| domain | founded_year | HQ Location |
An in vitro assay platform is provided for diagnostic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Correlia Biosystems
Frequently Asked Questions about Correlia Biosystems
When was Correlia Biosystems founded?
Correlia Biosystems was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Correlia Biosystems located?
Correlia Biosystems is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is Correlia Biosystems a funded company?
Correlia Biosystems is a funded company, having raised a total of $10.95M across 7 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Jul 01, 2014.
What does Correlia Biosystems do?
Correlia Biosystems is engaged in developing advanced protein quantification solutions through its PIXI platform, utilizing proprietary microfluidic gel technology. The company operates in the biotechnology sector, supporting applications in biopharmaceutical analysis, cell and gene therapy, and synthetic biology. Its solutions are designed for efficiency with ultra-low sample input, rapid turnaround, and high sensitivity, aiding scientific discovery in proteomics. Collaboration with top pharmaceutical companies is maintained to enhance assay development and laboratory integration.
Who are the top competitors of Correlia Biosystems?
Correlia Biosystems's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
What products or services does Correlia Biosystems offer?
Correlia Biosystems offers PIXI Benchtop Automated Immunoassays.
Who are Correlia Biosystems's investors?
Correlia Biosystems has 4 investors. Key investors include HHS, Neotribe, Cota Capital, and Y Combinator.